Further corroborating that blood neurofilaments increase in at-risk individuals nearing phenoconversion are studies of presymptomatic individuals with mutations in C9orf72 (associated with ALS and FTD), or in GRN or MAPT (associated with FTD). The gene discussed is MAPT; the disease is amyotrophic lateral sclerosis.